Laddar...
Basal Insulin Use With GLP-1 Receptor Agonists
IN BRIEF The combination of basal insulin and a glucagon-like peptide 1 receptor agonist is becoming increasingly common and offers several potential benefits to patients with type 2 diabetes. Clinical studies have demonstrated improved glycemic control and low risks of hypoglycemia and weight gain...
Sparad:
| I publikationen: | Diabetes Spectr |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
American Diabetes Association
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5001217/ https://ncbi.nlm.nih.gov/pubmed/27574369 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/diaspect.29.3.152 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|